GeoVax Labs, Inc.(NASDAQ : GOVX)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
Health Technology » Biotechnology
|GILD||Gilead Sciences, Inc.||-0.15%||71.77||1.0%||$503.51m|
|REGN||Regeneron Pharmaceuticals, Inc.||-0.14%||615.24||2.7%||$435.16m|
|VRTX||Vertex Pharmaceuticals, Inc.||3.30%||234.06||1.9%||$373.05m|
|SNSS||Sunesis Pharmaceuticals, Inc.||2.26%||3.17||0.7%||$221.59m|
|EXAS||EXACT Sciences Corp.||4.02%||78.43||18.0%||$156.45m|
|ARNA||Arena Pharmaceuticals, Inc.||0.20%||92.65||13.7%||$151.27m|
|ALNY||Alnylam Pharmaceuticals, Inc.||0.34%||148.50||8.2%||$147.48m|
|BMRN||BioMarin Pharmaceutical, Inc.||2.34%||90.22||4.2%||$114.62m|
GeoVax Labs, Inc. is a clinical-stage biotechnology company, which engages in the development of immunotherapies and vaccines against cancers and infectious diseases using a novel vector vaccine platform. It focuses on preventive vaccines against hemorrhagic fever viruses such as Ebola, Sudan, Marburg, and Lassa fever; Zika virus and malari; human immunodeficiency virus (HIV); as well as immunotherapies for solid tumor cancers. The company was founded in June 1988 and is headquartered in Smyrna, GA.